Nanox (NASDAQ: NNOX) announced plans to showcase its medical imaging technologies at the Radiological Society of North America (“RSNA”) 2026 Annual Meeting, scheduled for Nov. 29 through Dec. 2 in Chicago. At booth #1759 (South Hall Level 3), the company will demonstrate Nanox.ARC X, its U.S. Food and Drug Administration (“FDA”)-cleared multi-source digital tomosynthesis system recognized among TIME’s Best Inventions of 2026, alongside Nanox.AI, which uses FDA-cleared artificial intelligence (“AI”) algorithms to analyze routine computed tomography (“CT”) scans for early signs of chronic conditions. Nanox will also highlight its USARAD teleradiology services and Nanox Health IT solutions.
The company plans to preview innovations under development, including multiplanar and volumetric reconstruction, pediatric imaging indications and Mobile Nanox.ARC, as well as AI-based aortic valve calcification assessment and body composition. These developmental capabilities are not cleared or approved for clinical use, and features, indications and availability may change. Nanox CEO Erez Meltzer and Lawrence Tanenbaum, MD, Chief Medical Officer, U.S., Nanox, will deliver an Industry Expert Theater presentation on Nov. 30 at 10:30 am CT, followed by an Innovation Theater presentation on Dec. 1 at 11:00 am CT by Cedars-Sinai cardiologist Ofir Koren, MD, highlighting an aortic valve calcification AI solution.
To view the full press release, visit https://nnw.fm/M2sbi
NOTE TO INVESTORS: The latest news and updates relating to NNOX are available in the company’s newsroom at http://nnw.fm/NNOX
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer